search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
K2025 – MATERIALS | EXHIBITION PREVIEW


additive, it offers a drop-in solution to incumbent EAs that is regulatory-compliant. “Polyolefin resin producers will benefit from this, as its anti-static properties help ensure the polymer powder does not cling to the reactor wall during polymerisation,” said Laura Juhl, application manager for bio-speciality additives at Palsgaard. “This stabilises reaction temperature, sustains a high production performance and enables consistent product quality.” Einar 987 is effective at low dosages of 100-300 ppm and helps deliver long catalyst mileage without any compromise in performance. Palsgaard has already conducted several trials of it with resin producers. � www.palsgaard.com


Paques Biomaterials has opened a small PHA production facility in Emmen, in the Netherlands, which uses a proprietary bacterial process. The company is following a two-step approach,


said executives Joao Sousa and Richard Schrama. Paques is actively seeking


partners who will license the process technology and then intends to buy the output from these partners and purify it at its own plant. It aims to sell 50 licences by 2035. Board materials producer Eska is one current


partner in Europe which is planning to use process water as feedstock at a plant with 1,500 tonnes/year production capacity. Paques and another partner, Looop, have signed a deal to produce PHA from agri-food waste streams at a plant with a capacity of 3,000-6,000 tonnes/year. The Paques plant in Emmen has started small-scale operations from 25 kg/day but the company is expecting to scale up the plant. The final investment decision will be made after more offtake agreements have been signed. � www.paquesbiomaterials.nl


Polyplastics will unveil the latest advances in its Durafide polyphenylene sulphide (PPS) and Topas cyclic olefin copolymer (COC) technologies at K2025. The new Durafide grade is now available as a


Durast fine powder, with a unique spherical shape and precisely controlled, narrow particle size distribution. The company is also extending the use of Durafide to lithium-ion battery components,


www.injectionworld.com M


and launching new grades for laser-weldable applications – with enhanced perfor- mance and design flexibility. The company is also building a


new 25,000-tonnes/year Topas COC plant in Leuna, Germany that will help it meet growing demand. The facility will free up capacity for production of Topas grades used in pharmaceutical and medical packaging at its Oberhausen plant. � www.polyplastics-global.com


At K2025 later this year,Wacker will present its new Elastosil eco LR 5003 grade. The non-postcure liquid silicone rubber (LSR) is


aimed at the large-scale manufacture of products for the food industry and other sensitive areas. As far as volatiles content are concerned, moulded parts comply with limits stipulated by the German Federal Institute for Risk Assessment (BfR) even without postcuring. They also meet the requirements of the US Food and Drug Administration (FDA) for food-contact products. As a result, it can be used to make products such as drinking straws, baking tins and dough scrapers. During the show, the material will be used to injection-mould mouthpieces for water bottles designed by Air Up, with equipment from Arburg and Rico Elastomere Projecting. Last year, Wacker built a new silicone production site in Karlovy Vary in the Czech Republic. From the end of 2025, it will produce room- temperature curing silicones – and, from 2028, silicone rubber. The investment, in the ‘low triple-digit million Euros’ range, will create 200 new jobs in


I


the first expansion phase. Customised silicone elastomers are needed


where conventional materials cannot meet increas- ing requirements, in areas such as electromobility, renewable energies and the expansion of electric- ity grids. “To meet the growing demand for such solu- tions in the long term, we need to lay the necessary groundwork now,” said Christian Kirsten, executive board member at Wacker. The new site comple- ments Wacker’s existing production sites in Burghausen and Nünchritz, in Germany. � www.wacker.com


Above: Paques Biomaterials has developed a bacterial process to produce bioplastics


Left: Wacker Elastosil LR 5003 will be made into a water bottle mouthpiece at K2025


� October 2025 | INJECTION WORLD 35


A


I


M


C


A G


K


E :


E


P A


R


Q


U


E


S


A


G


:


E


W


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40